Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 6/20 | 0.62 |
| ▸ | CA9 | Q16790 | 4/20 | 0.62 |
| ▸ | CA12 | O43570 | 2/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | CA1 | P00915 | 5/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | ALB | P02768 | 1/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
| ▸ | CA7 | P43166 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.48 |
| ▸ | MMP2 | P08253 | 2/20 | 0.47 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.47 |
| ▸ | PLAU | P00749 | 1/20 | 0.47 |
| ▸ | HPN | P05981 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | CA4 | P22748 | 1/20 | 0.46 |
| ▸ | MMP1 | P03956 | 1/20 | 0.44 |
| ▸ | MMP9 | P14780 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3969093 | 0.88 | CA2 (0.60) | CA2CA9CA12ALDH1A1TSHR | |
| SCHEMBL30887502 | 0.86 | CA2 (0.60) | CA2CA9CA12ALDH1A1TSHR | |
| SCHEMBL10692687 | 0.81 | CA2 (0.62) | CA2CA9CA12ALDH1A1TSHR | |
| SCHEMBL28659487 | 0.81 | CA2 (0.55) | CA2CA9CA12ALDH1A1TSHR | |
| SCHEMBL14539177 | 0.79 | CA2 (0.60) | CA2CA9CA12ALDH1A1TSHR | |
| SCHEMBL31014162 | 0.79 | CA2 (0.56) | CA2CA9CA12ALDH1A1TSHR | |
| SCHEMBL13966856 | 0.78 | CA2 (0.51) | CA2CA9CA12ALDH1A1TSHR | |
| SCHEMBL13941902 | 0.78 | CA2 (0.51) | CA2CA9CA12ALDH1A1TSHR | |
| SCHEMBL13941904 | 0.78 | CA2 (0.51) | CA2CA9CA12ALDH1A1TSHR | |
| SCHEMBL13966628 | 0.78 | CA2 (0.51) | CA2CA9CA12ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3390344-B1 | IMPROVED METHOD FOR SYNTHESISING PARTIALLY N-HYDROXYETHYLATED TERTIARY 1,6-HEXANEDIAMINES | IFP ENERGIES NOW (FR) | 2020-12-02 | — | — | EP | disclosed |
| US-10618866-B2 | Method for synthesising partially N-hydroxyethylated tertiary 1,6-hexanediamines | IFP Energies Nouvelles (FR) | 2020-04-14 | — | — | US | disclosed |
| US-20190002392-A1 | IMPROVED METHOD FOR SYNTHESISING PARTIALLY N-HYDROXYETHYLATED TERTIARY 1,6-HEXANEDIAMINES | IFP Energies Nouvelles (FR) | 2019-01-03 | — | — | US | disclosed |
| EP-3390344-A1 | IMPROVED METHOD FOR SYNTHESISING PARTIALLY N-HYDROXYETHYLATED TERTIARY 1,6-HEXANEDIAMINES | IFP Energies nouvelles (FR) | 2018-10-24 | — | — | EP | disclosed |
| WO-2017102659-A1 | IMPROVED METHOD FOR SYNTHESISING PARTIALLY N-HYDROXYETHYLATED TERTIARY 1,6-HEXANEDIAMINES | IFP Energies Nouvelles (FR) | 2017-06-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190002392-A1 | IMPROVED METHOD FOR SYNTHESISING PARTIALLY N-HYDROXYETHYLATED TERTIARY 1,6-HEXANEDIAMINES | BHMT2, DNMT1, DNMT3A | CA2 4700/4885CA9 4184/4885CA12 4587/4885 |
| US-10618866-B2 | Method for synthesising partially N-hydroxyethylated tertiary 1,6-hexanediamines | BHMT2, DNMT1, HNMT | CA2 4732/4885CA9 4310/4885CA12 4574/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.